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were positive for hepatitis B surface antigen; 28 had been tested before the incident and two were found to be positive when tested because of the incident. Nurses reported most of the incidents (256), with 76 being reported by student nurses. Doctors None of the staff in the 18 reported incidents with source patients positive for HIV antibody was given prophylactic zidovudine. Some of the incidents were considered not to pose an infection risk. In the remainder after discussion the staff members chose not to take zidovudine. Follow up HIV antibody tests on the staff concerned have given negative results so far.
Discussion
In our study 71% of staff reporting exposure to patients' blood were immune to hepatitis B virus. This compares with rates of 25%,5 73%,6 and 65%7 reported in other studies. This immunisation coverage is not necessarily equivalent to the coverage in the whole population of hospital staff; we are currently investigating this.
We do not know the actual number of blood exposure incidents that occurred during the study period, but other studies have emphasised the underreporting of contamination incidents, especially among doctors.8 The higher proportion of sharps incidents reported by doctors compared with nurses may be because doctors are more likely to report sharps injuries than other incidents. We are trying to improve reporting rates: we have established a special telephone number for reporting incidents, medical students and junior doctors are given talks and written information about reporting, and we have been surveying all blood exposures in operating theatres and will feedback the results to the staff concerned. High reporting rates are important because reported incidents inform our continuing efforts to reduce incidents by changing practices and introducing safer equipment.
The main benefit of testing known source patients was the value of negative results. We were able to avoid giving hepatitis B immunoglobulin to several staff and to reassure most staff about the risk of HIV transmission from the incident. Many staff are extremely worried after incidents and are relieved to know the patient's HIV antibody status. No staff member has so far chosen to take prophylactic zidovudine. The value of zidovudine after needlestick injuries from HIV positive patients is unproved,9'0 and its failure to prevent seroconversion has been documented. Testing for hepatitis B surface antigen and HIV antibodies was undertaken in only about halfofeligible source patients. The main problem was one of logistics; it proved difficult to test patients who had gone home when the incident was reported. A study from the United States also reported logistical problems in testing source patients. '4 We have tried to organise testing at subsequent outpatient visits, but this often does not work. For incidents that occur in the community patients are visited by an occupational health nurse together with the district nurse after liaison with the general practitioner.
In the early months of this study clinical teams were often unwilling to approach their patients, especially for HIV testing. We tackled this problem by discussions with senior clinicians and by running training sessions for medical students and junior doctors and providing material to help them approach patients. Counselling before HIV testing can and should be undertaken by other health care workers as well as by specialist counsellors. '5 6 It is debatable whether clinicians should have the right to veto their patients being approached for testing after blood exposure incidents. The rights of the staff member have to be considered as well as the possible adverse effects on the patient. The patient, once approached, has the option to refuse, although in this study few did so. For most of the incidents reported during this study it was possible to advise and treat the staff members based on information about themselves and the source patients. We need to increase the proportion of source patients tested for blood borne viruses after incidents and to increase further the proportion of staff immunised against hepatitis B virus.
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Introduction
An excess of leukaemia has been observed after treatment of a variety of adult' 6 and childhood cancers.78 Case-control studies have identified specific groups of cytotoxic drugs that are associated with an increased risk of secondary leukaemias9''2; these and other studies have particularly identified alkylating agents as being associated with an increased risk of secondary leukaemia after adult and childhood cancers. Radiation exposure is undoubtedly involved in some leukaemias. 13 There have also been suggestions that the epipodophyllotoxins may be related to an increased risk of subsequent leukaemias.112' We report the results of a population based cohort study and a casecontrol study carried out (a) to estimate the absolute risk of secondary leukaemia after childhood cancer in Britain, and (b) to determine those aspects oftreatment related to an increased relative risk of secondary leukaemia.
Methods

PATHOLOGICAL CONFIRMATION OF NEOPLASMS
Each case included in the case-control study had representative slides of both the first and second neoplasms centrally reviewed and confirmed by a paediatric histopathologist (HBM). In addition, each possible occurrence of leukaemia after an initial leukaemia or non-Hodgkin's lymphoma was centrally reviewed by a haematologist (JMC). For 
